Stock ESLA ESTRELLA IMMUNOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Estrella Immunopharma, Inc.

Equities

ESLA

US2975841048

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
1 USD -1.48% Intraday chart for Estrella Immunopharma, Inc. -4.76% -9.91%
May. 15 Estrella Immunopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Jan. 30 Estrella Immunopharma, Inc. announces an Equity Buyback for $1 million worth of its shares. CI

Valuation

Fiscal Period: June 2022 2023
Capitalization 1 - -
Enterprise Value (EV) 1 - -
P/E ratio - -1.24 x
Yield - -
Capitalization / Revenue - -
EV / Revenue - -
EV / EBITDA - -
EV / FCF - -
FCF Yield - -
Price to Book -1.69 x -3.75 x
Nbr of stocks (in thousands) - -
Reference price 2 10.00 10.84
Announcement Date 12/19/22 10/11/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2021 2022 2023
Net sales - - -
EBITDA - - -
EBIT 1 -0.7337 -1.685 -11.11
Operating Margin - - -
Earnings before Tax (EBT) 1 -0.7337 -1.685 -11.11
Net income 1 -0.7337 -1.685 -11.11
Net margin - - -
EPS - - -8.751
Free Cash Flow - - 2.813
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 12/19/22 12/19/22 10/11/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: June 2021 2022 2023
Net Debt - - -
Net Cash position - 4.09 2.46
Leverage (Debt/EBITDA) - - -
Free Cash Flow - - 2.81
ROE (net income / shareholders' equity) - - 799%
ROA (Net income/ Total Assets) - - -175%
Assets 1 - - 6.36
Book Value Per Share - -5.910 -2.890
Cash Flow per Share - 23.20 0.6100
Capex - - -
Capex / Sales - - -
Announcement Date 12/19/22 12/19/22 10/11/23
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Bio Therapeutic Drugs

1st Jan change Capi.
ESTRELLA IMMUNOPHARMA, INC. Stock Estrella Immunopharma, Inc.
-9.91% 36.61M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+12.30% 116B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+12.15% 106B
BIONTECH SE Stock BioNTech SE
-8.14% 23.89B
ARGENX SE Stock argenx SE
-1.69% 21.58B
GENMAB A/S Stock Genmab A/S
-10.60% 18.96B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.25% 16.96B
BEIGENE, LTD. Stock BeiGene, Ltd.
-15.33% 16.33B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+5.80% 14.14B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+28.03% 12.02B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ESLA Stock
  4. Financials Estrella Immunopharma, Inc.